A multicenter, open label extension study to evaluate the safety of twice daily oral carvedilol in pediatric patients with chronic heart failure

Trial Profile

A multicenter, open label extension study to evaluate the safety of twice daily oral carvedilol in pediatric patients with chronic heart failure

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Oct 2006

At a glance

  • Drugs Carvedilol (Primary)
  • Indications Chronic heart failure
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top